Cargando…

Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma

This work was aimed at investigating the predictive value on prognosis, response to immunotherapy, and association with the immune landscape of costimulatory molecules in HCC patients. We acquired the clinicopathological information and gene expression of HCC patients from public available database...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yongjie, Zhou, Xin, Liu, Qingxin, Zhang, Zihan, Zhang, Wen, Ma, Jingqin, Yang, Minjie, Yu, Jiaze, Luo, Jianjun, Yan, Zhiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485710/ https://www.ncbi.nlm.nih.gov/pubmed/36148160 http://dx.doi.org/10.1155/2022/8973721

Ejemplares similares

Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Zhou, Yongjie, et al.
Publicado: (2022)

The Impact of Socioeconomic Status on Staging, Prognosis in Hepatocellular Carcinoma
por: Zhou, Yongjie, et al.
Publicado: (2022)

A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma
por: Chen, Bangjie, et al.
Publicado: (2022)

Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis
por: Zhou, Yongjie, et al.
Publicado: (2021)

Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance
por: Shi, Qin, et al.
Publicado: (2023)

The influence of shunting left/right portal vein branch on post-TIPS hepatic encephalopathy: a study protocol for multicenter randomized blinded controlled trial
por: Ma, Jingqin, et al.
Publicado: (2023)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

Landscape of costimulatory molecule signature in breast cancer and its prognostic significance
por: Kang, Changyuan, et al.
Publicado: (2023)

A costimulatory molecule-related signature in regard to evaluation of prognosis and immune features for clear cell renal cell carcinoma
por: Hua, Xiaoliang, et al.
Publicado: (2021)

Development of a Novel Endovascular Brachytherapy Stent: A Proof-of-concept Study
por: Du, Nan, et al.
Publicado: (2021)

The role of costimulatory molecules in glioma biology and immune microenvironment
por: Wang, Ji, et al.
Publicado: (2022)

Targeting Costimulatory Molecules to Improve Antitumor Immunity
por: Capece, Daria, et al.
Publicado: (2012)

Rcl1 suppresses tumor progression of hepatocellular carcinoma: a comprehensive analysis of bioinformatics and in vitro experiments
por: Jiaze, Yu, et al.
Publicado: (2022)

PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks
por: Zhou, Yongjie, et al.
Publicado: (2020)

Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction
por: Zhou, Yongjie, et al.
Publicado: (2023)

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
por: Fu, Yu, et al.
Publicado: (2020)

Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
por: Ge, Shengdong, et al.
Publicado: (2021)

A necroptosis‐related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma
por: Chen, Junliang, et al.
Publicado: (2022)

A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma
por: Yang, Ti, et al.
Publicado: (2023)

Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells
por: Carenza, Claudia, et al.
Publicado: (2019)

Microwave ablation combined with transarterial chemoembolization containing doxorubicin hydrochloride liposome for treating primary and metastatic liver cancers
por: Shi, Qin, et al.
Publicado: (2023)

A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma
por: Wang, Jiakun, et al.
Publicado: (2022)

Telomere maintenance genes-derived prognosis signature characterizes immune landscape and predicts prognosis of head and neck squamous cell carcinoma
por: Zou, Jianjun, et al.
Publicado: (2023)

The Landscape of Immune Cells Indicates Prognosis and Applicability of Checkpoint Therapy in Hepatocellular Carcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary tuberculosis
por: Zhao, Yunjuan, et al.
Publicado: (2021)

Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma
por: Wang, Liangliang, et al.
Publicado: (2022)

γδ T cell costimulatory ligands in antitumor immunity
por: McGraw, Joseph M., et al.
Publicado: (2022)

Neuroimmune semaphorins as costimulatory molecules and beyond
por: Chapoval, Svetlana P.
Publicado: (2018)

Altered expression of costimulatory molecules in dementias
por: Busse, Stefan, et al.
Publicado: (2021)

Origination of New Immunological Functions in the Costimulatory Molecule B7-H3: The Role of Exon Duplication in Evolution of the Immune System
por: Sun, Jing, et al.
Publicado: (2011)

A novel diagnostic model for predicting immune microenvironment subclass based on costimulatory molecules in lung squamous carcinoma
por: Duan, Fangfang, et al.
Publicado: (2022)

Prognostic costimulatory molecule-related signature risk model correlates with immunotherapy response in colon cancer
por: Huang, Wanze, et al.
Publicado: (2023)

Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma
por: Yang, Yanjie, et al.
Publicado: (2023)

Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma
por: Zhao, Yidi, et al.
Publicado: (2022)

An angiogenesis-related three-long non-coding ribonucleic acid signature predicts the immune landscape and prognosis in hepatocellular carcinoma
por: Wang, Wenjuan, et al.
Publicado: (2023)

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)

Characterization of mechanisms positioning costimulatory complexes in immune synapses
por: Siokis, Anastasios, et al.
Publicado: (2021)

Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer
por: Wu, Peng, et al.
Publicado: (2022)

Expression of costimulatory molecules in the bovine corpus luteum
por: Cannon, Matthew J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_3pvg64c2krqvaenq2dlkolv5s6